Show simple item record

dc.contributor.authorKesiime, Christine
dc.date.accessioned2023-01-25T09:34:50Z
dc.date.available2023-01-25T09:34:50Z
dc.date.issued2022-12-22
dc.identifier.citationKesiime, C. (2022). Parasite load and plasma cytokine levels in Trypanosoma Brucei infected rats administered with systemic IL-6 AND IL-10. (Unpublished Master's Dissertation). Makerere University, Kampala, Uganda.en_US
dc.identifier.urihttp://hdl.handle.net/10570/11704
dc.descriptionA dissertation submitted to the Directorate of Research and Graduate Training in partial fulfillment of the requirements for the award of the degree of Master of Science in Molecular Biology and Biotechnology of Makerere University.en_US
dc.description.abstractThe invasion of central nervous system (CNS) by trypanosomes is mediated by cytokine modulations and responses. The pro-inflammatory cytokine response facilitates the progression to the late stage while the anti-inflammatory cytokine responses hinder this progression. The study assessed parasite load and selected plasma cytokine levels in Trypanosoma brucei brucei infected rats administered with systemic IL-6 and IL-10 for novel therapeutic agent development. Wister albino rats were infected with Trypanosoma brucei brucei GVR35 and then administered with IL-6, IL- 10 or combined IL-6 and IL-10 on day 11 post-infection. Monitoring of blood trypanosome density from day 11-17 post-infection was by microscopy. Trypanosome density in CNS was determined by real-time quantitative PCR for trypanosome Pfr2 gene copies. Plasma cytokine levels were measured by sandwich Enzyme-Linked Immuno Sorbent Assay. Data was statistically analysed using Graphpad Prism 8.0 at p<0.05 significance. There was significant variation in blood parasite density across treatment groups post-infection (p=0.047). A significant difference between Diminazene aceturate and IL-10 mono-treatment groups in blood parasite density (p=0.001) was observed. However, no significant variation in blood parasite density when Diminazene aceturate treatment was compared to IL-6 mono-treatment and IL- 6/IL-10 combination treatment groups (p=0.225). There was a significant difference observed in rat survival across treatment groups (p=0.0001). The results showed significant variation of CNS trypanosome Pfr2 copies across treatment groups at p<0.05. The study demonstrated that systemic administration of the anti-inflammatory cytokines IL-6 or/and IL-10 significantly reduced CNS parasitosis. Administration of IL-6 or IL-6/IL- 10 combination significantly down-regulated plasma IFN-γ and TNF-α levels (p<0.05). However, there was no significant reduction in plasma IFN-γ and TNF-α levels in IL- 10 treatment as compared to untreated infected rats. There was no significant difference in plasma IL-6 and IL-10 levels among the different treatments observed. Therefore, CNS invasion and survival of parasites may be susceptible to immunological modulation.en_US
dc.description.sponsorshipConsortium for Advanced Research Training in Africa (CARTA) and Government of Uganda through the Research Innovation Fund at Makerere University (RIF1/COVAB/008)en_US
dc.language.isoenen_US
dc.publisherMakerere Universityen_US
dc.subjectparasite loaden_US
dc.subjectcytokinesen_US
dc.subjecttrypanosomesen_US
dc.subjectTrypanosoma Bruceien_US
dc.subjectratsen_US
dc.subjectsystemic IL-6 and IL-10en_US
dc.titleParasite load and plasma cytokine levels in Trypanosoma Brucei infected rats administered with systemic IL-6 AND IL-10en_US
dc.typeThesisen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record